Paul Crocker is a Professor of Glycoimmunology and Head of the Division of Cell Signaling and Immunology at the University of Dundee in Scotland. Paul is a world leader in the study of glycan-dependent regulation of immune and inflammatory responses. He pioneered the discovery of the Siglecs, a family of receptors found on immune cell surfaces that recognizes sialic acid-containing structures and regulates immune responses.
Current role
Co-founder & Scientific Advisor at Atalanta Therapeutics
Co-Founder & Scientific Advisor at PMV Pharmaceuticals
Co-Founder & Scientific Advisor at Vaccitech
Co-founder & Scientific Advisor at InterVenn Biosciences
Co-Founder & Scientific Advisor at HiberCell